Affiliation:
1. Department of Obstetrics and Gynecology, Università Cattolica del Sacro Cuore (M.Gu., D.R., M.Gi., R.S., L.S., R.A., A.L.), 00168 Rome, Italy
2. OASI Institute for Researche (A.L.), 94018 Troina, Italy
Abstract
Abstract
The aim of this study was to investigate the effects of the new estro-progestinic containing the antimineralcorticoid progestogen drospirenone (DRSP) in women with polycystic ovary syndrome (PCOS). Fifteen hirsute PCOS patients were treated with 30 μg ethinyl estradiol plus 3 mg DRSP for 12 cycles. Ultrasonographic pelvic exams, evaluation of hirsutism scores, and hormonal and lipid profile assays were performed at baseline and after three, six, and 12 cycles of treatment. An oral glucose tolerance test and euglycemic hyperinsulinemic clamp were also performed, except at the third cycle. The treatment was well tolerated, and all women attained satisfactory cycle control. Hirsutism significantly improved from the sixth cycle onward. Body weight and fat distribution as well as blood pressure remained stable throughout the treatment. Plasma levels of LH, testosterone, SHBG, and, consequently, the free androgen index significantly fell from the third cycle on. Dehydroepiandrosterone sulfate and 17-hydroxyprogesterone significantly decreased after six cycles. The treatment did not affect glycoinsulinemic homeostasis. A trend toward an increase was seen for total cholesterol, triglycerides, and high- and low-density lipoproteins (HDL and LDL) plasma concentrations, although all parameters remained within the normal range. No modifications in total cholesterol/HDL and HDL/LDL ratios were induced by the therapy. The ethinyl estradiol/DRSP combination seems to be effective in ameliorating clinical and hormonal features of PCOS.
Subject
Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference43 articles.
1. Polycystic ovary syndrome.;Franks;N Engl J Med,1995
2. Results of an open one-year study with Diane 35 in women with polycystic ovary syndrome.;Golland;Ann NY Acad Sci,1993
3. Long term treatment with the combination ethinyl-estradiol and cyproterone acetate in polycystic ovary syndrome.;Falsetti;Contraception,1990
4. Safety and efficacy of a new oral contraceptive containing drospirenone;Shulman;J Reprod Med,2002
5. Evolution of progestins;Thorneycroft;Focus on the novel progestin drospirenone. J Reprod Med,2002
Cited by
130 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献